# A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation

Study · id `cardio:ct-nct02789358` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02789358](<https://clinicaltrials.gov/study/NCT02789358>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02789358

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

## Technical summary

Registry record NCT02789358. Randomized; single masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 140 participants (enrolled count; ClinicalTrials.gov record NCT02789358, source copy `cardio:ctgov-nct02789358-2019-08-15`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02789358, source copy `cardio:ctgov-nct02789358-2019-08-15`, retrieved 2026-10-26)
- Primary completion: 2016-06 (actual) (ClinicalTrials.gov record NCT02789358, source copy `cardio:ctgov-nct02789358-2019-08-15`, retrieved 2026-10-26)
- Completion: 2016-08 (actual) (ClinicalTrials.gov record NCT02789358, source copy `cardio:ctgov-nct02789358-2019-08-15`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT02789358, source copy `cardio:ctgov-nct02789358-2019-08-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02789358-2019-08-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation
- Acronym: plusONE
- Condition: Atrial Fibrillation
- Intervention (Other): Conventional cryotherapy dosage
- Intervention (Other): Experimental cryotherapy dosage
- Intervention (Device): Arctic Front Advance ST Cryoenergy Balloon Catheter
- Intervention (Drug): Adenosine triphosphate
- Intervention (Device): nECG platform Nuubo®
- Lead sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Fundación para la Investigación del Hospital Clínico de Valencia (`cardio:org-fundacion-para-la-investigacion-del-hospital-clinico-de-7ad3f9`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Time-to-Effect-Based Dosing Strategy for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the plusONE Multicenter Randomized Controlled Noninferiority Trial (`cardio:pubmed-29247029`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9c5bb22e468e8a4970ea5370ba2064be15715db97975c50cc452766bc759c667
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
